Law Office of Brodsky & Smith, LLC Announces Investigation of Adolor Corporation
October 25 2011 - 11:30PM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
Adolor Corporation (“Adolor” or the “Company”) (Nasdaq: ADLR)
relating to the proposed acquisition by Cubist Pharmaceuticals,
Inc. (“Cubist”).
Under the terms of the transaction Adolor shareholders would
receive $4.25 in cash and one Contingent Payment Right entitling
the holder to receive additional cash payment payments of up to
$4.50, if certain benchmarks are achieved, for each share of Adolor
stock they own. The investigation concerns possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of Adolor for not acting in the Adolor shareholders' best
interests in connection with the sale process to Cubist. The
transaction may undervalue Adolor as a result of failing to
adequately shop the Company.
If you own shares of Adolor stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L. Brodsky, Esquire or Evan J.
Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, visiting
http://brodsky-smith.com/348-adlr-adolor-corporation.html, or by
calling toll free 877-LEGAL-90.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024